FDA Clearance Tracker · P140017-S004
ENSEMBLE II TRANSCATHETER VALVE DELIVERY SYSTEM
Last checked: Nov 20, 2026Latest source record: Sep 12, 2016 (this decision)Source: openFDAMethods & limitations
Decided
Sep 12, 2016
Approved
Time to decision
140 days
Received Apr 25, 2016. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
The decision
- FDA number
- P140017-S004
- Device name
- ENSEMBLE II TRANSCATHETER VALVE DELIVERY SYSTEM
- Applicant
- Medtronic, Inc.
- Applicant location
- Mounds View, MN
- Received
- Apr 25, 2016
- Decided
- Sep 12, 2016
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P140017
Device type
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
Approval for a product line extension to the Ensemble Transcatheter Valve Delivery System.
Source documents
Other decisions for Medtronic, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K263596 · Decided Oct 29, 2026 · 29 days after receipt
Device type: Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass (DWF) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.